Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > The Seven Questions Every Investor Needs To Answer

Tags

  • combination
  • investors
  • cycle
  • seven questions
  • developing combination
  • seven questions

  • Links

  • 20 Questions To Ask Before Creating An eBook
  • Web Site Promotion: How To Find A Niche Market
  • Getting Your Way Out Purchasing A Bank's Foreclosure Home
  • Top Articles - The Seven Questions Every Investor Needs To Answer

    Most people invest with the aim of making a profit but of course making a loss is always a possibility. To help you make the best investment decisions there are seven questions that yo
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    u need to be able to answer. Your answers will much better equip you to make profitable investment decisions.

    Most people hate making decisions. They stall and stall until in the end
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    the decision makes itself. This is a great strategy if your aim is to bob along on the wave of chance, but how many people do you think really get rich by chance? The self made rich, t
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    he successful investors and all people who are in control of their own life, take that control by developing the habit and skill of being a good decision maker.

    In order to make a goo
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    investment decision in regards to investing you need to be able to answer these seven questions.

    Question 1: What is most likely to happen?

    In order to answer this
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    question you need to understand what drives capital growth in that particular form of investment. If you don't have this knowledge it's time to invest in some appropriate education bef
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ore you risk your money.

    Question 2: How can I best capitalize on that?

    Every market is constantly a mixture of opportunities and difficulties. The trick is being ab
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    le to recognize the opportunities. Opportunities that are obvious to an expert investor are often invisible to a novice or intermediate level investor. Recognizing opportunity comes fr
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    m a combination of knowledge, experience, and creative thinking.

    Question 3: What could go wrong?

    Optimists often lose their money because they never look at what co
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    uld go wrong. On the other hand pessimists see so many potential problems that they are too afraid to invest and so make no profit. It is important to learn how to switch between the t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    wo states as required.

    For question 3 you need a degree of pessimism. Make a list of all the things that could reasonably go wrong with the particular investment that you are consider
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ing.

    Question 4: How can I manage that risk?

    Not investing because there are risks involved is a sure way to stay broke. Every investment (and every business) has ri
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ks. Experienced investors will invest if they can manage the risks within their decided tolerance levels. If not, they look for a different investment.

    Question 5: How will I
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    cash flow this investment?

    Capital growth can make you rich but cash flow is the king. I have seen many unskilled investors lose money because they are so focused on the capi
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    tal growth potential of a particular investment and forget to assess whether they can cash flow it during the time it take for capital growth.

    This is particularly true with high grow
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    th residential property that often has low rental yield and therefore requires cash input each month to meet the loan repayments. Don't get in over your head.

    Question 6: What
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    will my strategy be in the event that I am right in my assessment?

    Collect profit and minimize losses is a wise motto for investors.

    If you are right in your assessment and
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    all goes well with your investment then how and when are you going to collect your profit?

    Question 7: What will my strategy be in the event that I am wrong in my assessment?<
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    /strong>

    Even the most experienced investor can make an incorrect assessment and invest when they should have declined. For this reason an experienced investor designs an exit strateg
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    y BEFORE he or she invests. Then if the investment goes the wrong way they already know what to do.

    Get good at answering the seven questions and your net worth will reap the benefits


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/102471/toparticles-The-Seven-Questions-Every-Investor-Needs-To-Answer.html">The Seven Questions Every Investor Needs To Answer</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/102471/toparticles-The-Seven-Questions-Every-Investor-Needs-To-Answer.html]The Seven Questions Every Investor Needs To Answer[/url]

    Related Articles:

    8 Personal Qualities of a Entrepreneur - from a South African Perspective

    Towards an Effective Newsletter

    How To Build A Website

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com